Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: Implications for mucosal vaccines

European Journal of Immunology

Volumn 35, Issue 9, 2005, Pages 2617-2626

  Rozis, George ^a   de Silva, Shamika ^b   Benlahrech, Adel ^a   Papagatsias, Timos ^a   Harris, Julian ^b   Gotch, Frances ^a   Dickson, George ^b   Patterson, Steven ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adenovirus vectors; Dendritic cells; Langerhans cells; Vaccines

Indexed keywords

ADENOVIRUS VECTOR; ALPHAVBETA5 INTEGRIN; CHIMERIC PROTEIN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; GREEN FLUORESCENT PROTEIN; INTEGRIN; MEMBRANE COFACTOR PROTEIN; PLASMID VECTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE; VITRONECTIN RECEPTOR;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ELECTROPORATION; FEMALE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTERNALIZATION; LANGERHANS CELL; MONOCYTE; PRIORITY JOURNAL; SKIN CELL; T LYMPHOCYTE ACTIVATION; TARGET CELL; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRUS IMMUNITY; VIRUS INFECTION;

ADENOVIRIDAE; ANTIGENS, CD34; ANTIGENS, CD40; DENDRITIC CELLS; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOPHENOTYPING; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; PLASMIDS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; UP-REGULATION; VIRAL VACCINES;

EID: 26044481156     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425939     Document Type: Article

References (28)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-251.
2. Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A. et al., Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 1999. 190: 1669-1678.
3. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., and Steinman, R. M., Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J. Exp. Med. 2002. 196: 1627-1638.
4. Porgador, A., Staats, H. F., Faiola, B., Gilboa, E., and Palker, T. J., Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J. Immunol. 1997. 158: 834-841.
5. Belyakov, I. M., Derby, M. A., Ahlers, J. D., Kelsall, B. L., Earl, P., Moss, B., Strober, W., and Berzofsky, J. A., Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc. Natl. Acad. Sci. USA 1998. 95: 1709-1714.
6. Staats, H. F., Bradney, C. P., Gwinn, W. M., Jackson, S. S., Sempowski, G. D., Liao, H. X., Letvin, N. L., and Haynes, B. F., Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J. Immunol. 2001. 167: 5386-5394.
7. Belyakov, I. M., Hammond, S. A., Ahlers, J. D., Glenn, G. M., and Berzofsky, J. A., Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 2004. 113: 998-1007.
8. Bruce, C. B., Akrigg, A., Sharpe, S. A., Hanke, T., Wilkinson, G. W.G., and Cranage, M. P., Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice. J. Gen. Virol. 1999. 80: 2621-2628.
9. Shiver, J. W., Fu, T. M., Chen, L., Casimiro, D. R., Davies, M. E., Evans, R. K., Zhang, Z. Q. et al., Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002. 415: 331-335.
10. Tillman, B. W., de Gruijl, T. D., Luykx-De Bakker, S. A., Scheper, R. J., Pinedo, H. M., Curiel, T. J., Gerritsen, W. R., and Curiel, D. T., Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J. Immunol. 1999. 162: 6378-6383.
11. Shayakhmetov, D. M., Carlson, C. A., Stecher, H., Li, Q. L., Stamatoyannopoulos, G., and Lieber, A., A high-capacity, capsid-modified hybrid adenovirus/adeno- associated virus vector for stable transduction of human hematopoietic cells. J. Virol. 2002. 76: 1135-1143.
12. Stecher, H., Shayakhmetov, D. M., Stamatoyannopoulos, G., and Lieber, A., A capsid-modified adenovirus vector devoid of all viral genes: Assessment of transduction and toxicity in human hematopoietic cells. Mol. Ther. 2001. 4: 36-44.
13. Gaggar, A., Shayakhmetov, D. M., and Lieber, A., CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 2003. 9: 1408-1412.
14. Dhodapkar, M. V., Steinman, R. M., Sapp, M., Desai, H., Fossella, C., Krasovsky, J., Donahoe, S. M. et al., Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 1999. 104: 173-180.
15. Ratzinger, G., Baggers, J., de Cos, M. A., Yuan, J. D., Dao, T., Reagan, J. L., Munz, C. et al., Mature human Langerhans cells derived from CD3(+) hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J. Immunol. 2004. 173: 2780-2791.
16. Dietz, A. B. and Vuk-Pavlovic, S., High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 1998. 91: 392-398.
17. Pereboev, A. V., Nagle, J. M., Shakhmatov, M. A., Triozzi, P. L., Matthews, Q. L., Kawakami, Y., Curiel, D. T., and Blackwell, J. L., Enhanced gene transfer to mouse dendritic cells using adenovioral vectors coated with a novel adapter molecule. Mol. Ther. 2004. 9: 712-720.
18. Rea, D., Havenga, M. J., van Den, A. M., Sutmuller, R. P., Lemckert, A., Hoeben, R. C., Bout, A. et al., Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J. Immunol. 2001. 166: 5236-5244.
19. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor α .2. Functional analysis. Blood 1997. 90: 1458-1470.
20. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., and Bhardwaj, N., Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001. 193: 233-238.
21. Rea, D., Schagen, F. H., Hoeben, R. C., Mehtali, M., Havenga, M. J., Toes, R. E., Melief, C. J., and Offringa, R., Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J. Virol. 1999. 73: 10245-10253.
22. Schumacher, L., Ribas, A., Dissette, V. B., McBride, W. H., Mukherji, B., Economou, J. S., and Butterfield, L. H., Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses. J. Immunother. 2004. 27: 191-200.
23. Smith, S. G., Patel, P. M., Selby, P. J., and Jackson, A. M., The response of human dendritic cells to recombinant adenovirus, recombinant Mycobacterium bovis Bacillus Calmette Guerin and biolistic methods of antigen delivery: different induction of contact-dependant and soluble signals. Immunol. Lett. 2001. 76: 79-88.
24. Zhong, L., Granelli, P. A., Choi, Y., and Steinman, R. M., Recombinant adenovirus is an efficienct and non-perturbing genetic vector for human dendritic cells. Eur. J. Immunol. 1999. 29: 964-972.
25. Tillman, B. W., Hayes, T. L., deGruijl, T. D., Douglas, J. T., and Curiel, D. T., Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Canc. Res. 2000. 60: 5456-5463.
26. Tuettenberg, A., Jonuleit, H., Tuting, T., Bruck, J., Biermann, V., Kochanek, S., Knop, J., and Erik, A. H., Early adenoviral gene expression mediates immunosuppression by transduced dendritic cell (DC): Implications for immunotherapy using genetically modified DC. J. Immunol. 2004. 172: 1524-1530.
27. Graham, F. L. and Prevec, L., Methods for construction of adenovirus vectors. Mol. Biotech. 1995. 3: 207-220.
28. Graf, D., Korthauer, U., Mages, H. W., Senger, G., and Kroczek, R. A., Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 1992. 22: 3191-3194.